<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="rmv2163-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
 <label>TABLE 2</label>
 <caption>
  <p>Immunomodulatory and anti‐inflammatory properties of azithromycin</p>
 </caption>
 <table frame="hsides" rules="all">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">Property</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Effect</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Specific Findings</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Study</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">General anti‐inflammatory properties</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Destabilisation of NALP3 mRNA levels</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased IL‐beta production</td>
    <td align="left" valign="top" rowspan="1" colspan="1">LPS‐stimulated THP‐1 monocytes. AZM reduced IL‐1beta, NALP3 protein and NFκB activity</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lendermon et al
     <xref rid="rmv2163-bib-0065" ref-type="ref">
      <sup>65</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Inhibition of inflammatory cytokine release</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased CXCL8 (IL‐8), NFκB and AP‐1 from epithelial cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Clinical trial in recurrent genital 
     <italic>C. trachomatis</italic> infection. Decreased IL‐1beta, CXCL‐1, ‐5, ‐8, ‐9, CCL2, ‐5, MCL1, MAPK1
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Srivastava et al
     <xref rid="rmv2163-bib-0066" ref-type="ref">
      <sup>66</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Airway epithelial cell lines. Decrease in CXCL8 mRNA, and NFκB and AP‐1 binding</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cigana et al
     <xref rid="rmv2163-bib-0067" ref-type="ref">
      <sup>67</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased CXCL8 (IL‐8), MAPK and 8‐isoprostane in airway smooth muscle cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">IL‐17‐stimulated primary human airway smooth muscle cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Vanaudenaerde et al
     <xref rid="rmv2163-bib-0068" ref-type="ref">
      <sup>68</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased PGE2 synthesis</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human polymorphonuclear and mononuclear leukocytes. Decreased LPS‐induced PGE2 by suppression of cPLA2, COX‐1, COX‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Miyazaki et al
     <xref rid="rmv2163-bib-0069" ref-type="ref">
      <sup>69</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased TNF from cystic fibrosis airway epithelial cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human CF and non‐CF cell lines. Decreased TNF mRNA and protein and NFκB and Sp1 binding</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cigana et al
     <xref rid="rmv2163-bib-0070" ref-type="ref">
      <sup>70</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased GM‐CSF</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Airway epithelial (A549) cell lines. Reduced TNF‐induced GM‐CSF mRNA and protein expression</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yamasawa et al
     <xref rid="rmv2163-bib-0071" ref-type="ref">
      <sup>71</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Reduction of cytokine‐induced endothelin 1 expression in epithelial cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human bronchial epithelial cells. Erythromycin and clarithromycin reduced enfothelin‐1 expression</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Takizawa et al
     <xref rid="rmv2163-bib-0072" ref-type="ref">
      <sup>72</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of endocytosis/induction of phospholipidosis</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreases motility and fluidity of the plasma membrane</td>
    <td align="left" valign="top" rowspan="1" colspan="1">J774 macrophage cell line</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tyteca et al
     <xref rid="rmv2163-bib-0073" ref-type="ref">
      <sup>73</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Slows membrane trafficking towards lysosomes</td>
    <td align="left" valign="top" rowspan="1" colspan="1">J774 macrophage cell line</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tyteca et al
     <xref rid="rmv2163-bib-0074" ref-type="ref">
      <sup>74</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of fluid phase endocytosis of macromolecules</td>
    <td align="left" valign="top" rowspan="1" colspan="1">J774 macrophage cell line</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tyteca et al
     <xref rid="rmv2163-bib-0074" ref-type="ref">
      <sup>74</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Down‐regulates and delays recycling of surface transferrin receptors</td>
    <td align="left" valign="top" rowspan="1" colspan="1">J774 macrophage cell line</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tyteca et al
     <xref rid="rmv2163-bib-0074" ref-type="ref">
      <sup>74</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of pinocytosis of macromolecules and their transport from plasma membrane to endo/lysosomes</td>
    <td align="left" valign="top" rowspan="1" colspan="1">J774 macrophage cell line</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tyteca et al
     <xref rid="rmv2163-bib-0074" ref-type="ref">
      <sup>74</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Increase of lysosomal hydrolase activity in fibroblasts</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Fibroblast homogenates. Increased activity of sulfatase A, phospholipase A1, cathepsin B</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gerbaux et al
     <xref rid="rmv2163-bib-0075" ref-type="ref">
      <sup>75</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Lysosomal enzyme depletion/extracellular secretion of lysosomal enzymes</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rat kidney cells. Redistribution of mannose 6‐phosphate receptor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ikeda et al
     <xref rid="rmv2163-bib-0076" ref-type="ref">
      <sup>76</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Effects on airway inflammatory cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Accumulation intracellularly within phagocytes</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prolonged macrolide retention intracellularly</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human in vivo 210 h T1/2 in neutrophils. Concentration in alveolar macrophages, in neutrophils, in phagocytic and epithelial cell lines</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Wildfeuer et al, Capitano et al, Bosnar et al
     <xref rid="rmv2163-bib-0077" ref-type="ref">
      <sup>77</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0078" ref-type="ref">
      <sup>78</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0079" ref-type="ref">
      <sup>79</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Prolonged AZM retention within neutrophils</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Concentrations 2000 to 3000 times higher in neutrophils than plasma</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Wilms et al
     <xref rid="rmv2163-bib-0080" ref-type="ref">
      <sup>80</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Accumulation of macrolides in alveolar macrophages</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human in vivo 500‐fold accumulation in alveolar macrophages</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lucchi et al, Capitano et al
     <xref rid="rmv2163-bib-0077" ref-type="ref">
      <sup>77</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0081" ref-type="ref">
      <sup>81</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Neutrophils</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of neutrophil chemotaxis</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Murine pseudomonas model and human neutrophils. Reduced neutrophil chemotaxis via ERK‐1 and ERK‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tsai et al
     <xref rid="rmv2163-bib-0082" ref-type="ref">
      <sup>82</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Down regulation of neutrophil chemokine production</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human blood. Decreased azurophilic granule enzyme activities</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Culić et al, Tsai et al
     <xref rid="rmv2163-bib-0083" ref-type="ref">
      <sup>83</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0084" ref-type="ref">
      <sup>84</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Attenuation of neutrophil oxidative burst</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human blood neutrophils</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Nozoe et al
     <xref rid="rmv2163-bib-0085" ref-type="ref">
      <sup>85</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Down regulation of MPO production</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human in vivo blood neutrophils. Decreased MPO concentration</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Culić et al
     <xref rid="rmv2163-bib-0084" ref-type="ref">
      <sup>84</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Increased neutrophil apoptosis</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human in vivo blood neutrophils. Increased neutrophil apoptosis 28 days post dose</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Culić et al
     <xref rid="rmv2163-bib-0084" ref-type="ref">
      <sup>84</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of neutrophil elastase and MMP9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human in vivo. Clarithromycin reduced airway neutrophil elastase and MMP9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Simpson et al
     <xref rid="rmv2163-bib-0086" ref-type="ref">
      <sup>86</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Macrophages</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Increased phagocytosis</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human alveolar macrophages. Increased phagocytosis of apoptotic bronchial epithelial cells and neutrophils</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hodge et al, Yamaryo et al
     <xref rid="rmv2163-bib-0087" ref-type="ref">
      <sup>87</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0088" ref-type="ref">
      <sup>88</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Macrophage lysosomes more resistant to oxidant challenge</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human alveolar macrophages ex vivo. Reduced oxidative lysosomal membrane permeabilisation</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Persson et al
     <xref rid="rmv2163-bib-0089" ref-type="ref">
      <sup>89</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Polarization towards M2 phenotype</td>
    <td align="left" valign="top" rowspan="1" colspan="1">In vitro polarised J774 macrophage cell line. Increased M2 markers mannose receptor, CD23, arginase, decreased CCR7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Murphy et al
     <xref rid="rmv2163-bib-0090" ref-type="ref">
      <sup>90</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Reduction in production of GM‐CSF and IL‐1beta</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Murine LPS challenge. Decreased GM‐CSF, IL‐1beta, TNF, CCL2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bosnar et al
     <xref rid="rmv2163-bib-0091" ref-type="ref">
      <sup>91</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Suppression of IL‐12p40 by macrophages</td>
    <td align="left" valign="top" rowspan="1" colspan="1">LPS‐stimulated macrophage cell lines. Decreased IL‐12p40 induction by inhibited AP‐1, NFAT, ICSBP binding</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yamauchi et al
     <xref rid="rmv2163-bib-0092" ref-type="ref">
      <sup>92</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Increased mannose receptor expression</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human in vivo trial. Increased mannose receptor expression and phagocytosis</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hodge et al
     <xref rid="rmv2163-bib-0093" ref-type="ref">
      <sup>93</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Decreased CXCL8 (IL‐8) production</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human ex vivo blood and lung macrophages. CXCL8 inhibited at 400 mg/L</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kurdowska et al
     <xref rid="rmv2163-bib-0094" ref-type="ref">
      <sup>94</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Dendritic cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Modulation towards a regulatory phenotype</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Monocyte‐derived dendritic cells enhanced IL‐10 release and inhibited IL‐6, IL‐12p40, CXCL10, CXCL11 and CCL22 release</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Polancec et al, Sugiyama et al
     <xref rid="rmv2163-bib-0095" ref-type="ref">
      <sup>95</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0096" ref-type="ref">
      <sup>96</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">CD40, CD86, and MHCII expression inhibited</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Murine bone marrow derived DCs and murine histoincompatible bone marrow transplant model. Decreased CD40 and CD86</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Iwamoto et al
     <xref rid="rmv2163-bib-0097" ref-type="ref">
      <sup>97</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0098" ref-type="ref">
      <sup>98</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Natural Killer cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of cytotoxic function through down regulation of perforin expression</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human NK cells. Decreased CD69, perforin and cytotoxicity</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lin et al
     <xref rid="rmv2163-bib-0099" ref-type="ref">
      <sup>99</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Effects on airway mucosal stromal cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Smooth muscle cells</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Antiproliferative effect</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rabbit tracheal smooth muscle cells. Reduced proliferation, increased autophagy</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Stamatiou et al
     <xref rid="rmv2163-bib-0100" ref-type="ref">
      <sup>100</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Relaxant effect</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rabbit tracheal smooth muscle cells. Smooth muscle relaxation</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Daenas et al
     <xref rid="rmv2163-bib-0101" ref-type="ref">
      <sup>101</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Airway epithelium</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Enhanced airway epithelial integrity</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Increased transepithelial electrical resistance by altered processing of tight junction proteins</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Asgrimsson et al, Halldorsson et al
     <xref rid="rmv2163-bib-0102" ref-type="ref">
      <sup>102</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0103" ref-type="ref">
      <sup>103</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Inhibition of inflammatory mucin release</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human cell lines and primary cells. Inhibition of MUC5AC production</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Imamura et al, Ribeiro et al
     <xref rid="rmv2163-bib-0104" ref-type="ref">
      <sup>104</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0105" ref-type="ref">
      <sup>105</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Modulated CXCL8 (IL‐8) production</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human bronchial epithelial cells. Increased CXCL8 release</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Shinkai et al
     <xref rid="rmv2163-bib-0106" ref-type="ref">
      <sup>106</sup>
     </xref>
    </td>
   </tr>
   <tr>
    <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1">Reduced CXCL8 (IL‐8)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human trial. Roxithromycin reduced CXCL8 in nasal lavage in chronic rhinosinusitis, with clinical improvement</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Wallwork et al, Yamada et al
     <xref rid="rmv2163-bib-0107" ref-type="ref">
      <sup>107</sup>
     </xref>, 
     <xref rid="rmv2163-bib-0108" ref-type="ref">
      <sup>108</sup>
     </xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="rmv2163-ntgp-0002">
  <fn id="rmv2163-note-0002">
   <p>Abbreviations: CCL, C‐C motif ligand; CD, cluster of differentiation; CF, cystic fibrosis; CXCL, C‐X‐C motif ligand; DPB, diffuse panbronchiolitis; COX, cyclooxygenase; cPLA2, cytosolic phospholipase A2; ERK, extracellular signal‐regulated kinase; GM‐CSF, granulocyte‐macrophage colony‐stimulating factor (CSF2); IL, interleukin; MAPK, mitogen‐activated protein kinase; MCL1, myeloid cell leukaemia sequence 1; NALP3, NACHT, LRR, and PYD domains‐containing protein 3; PGE2, Prostaglandin E2; TGF‐beta, transforming growth factor beta.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
